BEUDAMED
    FDA Adverse Event Injury Summary report: N

    OPTETRAK

    MDR report key: 16378505 · Received February 15, 2023

    Report

    Report Number
    1038671-2023-00171
    Event Type
    Injury
    Date Received
    February 15, 2023
    Date of Event
    January 3, 2008
    Report Date
    March 9, 2026
    Manufacturer
    EXACTECH, INC.
    Product Code
    JWH
    UDI-DI
    10885862048318
    PMA / PMN Number
    K032606
    Removal / Correction Number
    Z-0019-2022
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    FL, US
    Reporter Occupation
    003

    Narratives

    Additional Manufacturer Narrative · 0

    COMMON DEVICE NAME: PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER PLEASE NOTE THE CONCOMITANTS LISTED BELOW ARE FOR THE LEFT AND THE RIGHT KNEE.  IT WAS NOT POSSIBLE TO DETERMINE WHICH PRODUCTS HAVE BEEN IMPLANTED SPECIFICALLY IN THE LEFT OR RIGHT KNEE BASED ON THE INFORMATION RECEIVED FOR THIS PATIENT. REFER TO 1038671-2023-00169 FOR LEFT KNEE. CONCOMITANTS: 0999305, 200-03-35 - ONE PEG PATELLA 35MM. 1055246, 200-03-35 - ONE PEG PATELLA 35MM. 1070663, 200-04-33 - CEMENTED FINNED TIB. TRA SZ 3F/3T. 1131262, 200-04-33 - CEMENTED FINNED TIB. TRA SZ 3F/3T. 1092784, 234-02-03 - OPTETRAK ASY,PS CEMENTED FEMORAL, SZ 3. 1123069, 234-03-03 - OPTETRAK ASY,PS CEMENTED FEMORAL, SZ 3. 1098144, 204-23-11 - PS TIBIAL INSERTS SZ 3, 11MM. SERIAL NUMBER (B)(4) IS CONFIRMED TO HAVE BEEN PACKAGED IN A VACUUM BAG THAT DOES NOT CONTAIN EVOH. 0882761, 204-23-11 - PS TIBIAL INSERTS SZ 3, 11MM. SERIAL NUMBER (B)(4) IS CONFIRMED TO HAVE BEEN PACKAGED IN A VACUUM BAG THAT DOES NOT CONTAIN EVOH. ADDITIONAL INFORMATION, INCLUDING THE PRODUCT INVESTIGATION, WILL BE SUBMITTED WITHIN 30 DAYS OF RECEIPT.

    Additional Manufacturer Narrative · 0

    THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY CORRECTED INFORMATION. THE FOLLOWING SECTIONS WERE CORRECTED: H6, H11. THE REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. NO DEVICE WAS RETURNED FOR EVALUATION; FURTHER, PHOTOGRAPHS AND/OR RADIOGRAPH IMAGES WERE NOT PROVIDED FOR REVIEW. IN AUGUST OF 2021, IT WAS DISCOVERED THAT A BAG USED IN THE PACKAGING OF OUR POLYETHYLENE INSERTS HAD BEEN PRODUCED OUTSIDE OF OUR QUALITY SPECIFICATIONS. THE USE OF THESE NON-CONFORMING BAGS MAY ENABLE INCREASED OXYGEN DIFFUSION TO THE UHMWPE (ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE) INSERT, RESULTING IN INCREASED OXIDATION OF THE MATERIAL RELATIVE TO INSERTS PACKAGED WITH BAGS THAT CONFORM TO SPECIFICATIONS. FOR INSERTS WITH GREATER THAN FIVE YEARS OF SHELF LIFE, INCREASED OXIDATION OF THE INSERTS CAN LEAD TO PREMATURE POLYETHYLENE WEAR RESULTING IN A REVISION SURGERY. HOWEVER, WHILE IT WAS PACKAGED IN A NON-CONFORMING VACUUM BAG, THIS TIBIAL INSERT WAS ON THE SHELF FOR LESS THAN 5 YEARS BEFORE IT WAS IMPLANTED. A REVIEW OF COMPLAINT HISTORY DETERMINED THAT NO FURTHER ACTION IS REQUIRED AS NO TRENDS WERE IDENTIFIED. A DEFINITIVE ROOT CAUSE WAS UNABLE TO BE DETERMINED; HOWEVER, MAY HAVE RESULTED FROM PROSTHESIS WEAR, LOOSENING, AND INSTABILITY OR DUE TO INCLUSION OF THE POLYETHYLENE IN THE PACKAGING RECALL. ADDITIONALLY, THESE DEVICES APPEAR TO HAVE BEEN IMPLANTED FOR OVER TEN YEARS PRIOR TO THE REPORTED EVENT. POTENTIAL CONTRIBUTIONS OF USER- AND PATIENT-RELATED CONSIDERATIONS TO THE EVENT COULD NOT BE ASSESSED AS THE DEVICES WERE NOT AVAILABLE FOR EVALUATION AND IMAGES AND RADIOGRAPHS, WERE NOT PROVIDED. IF ANY FURTHER INFORMATION IS OBTAINED THAT WOULD CHANGE OR ALTER ANY INFORMATION PROVIDED, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY.

    Additional Manufacturer Narrative · 0

    ADDITIONAL INFORMATION - A2, A3, B6, B7, D4. SN AND EXPIRATION DATE, H6 HEALTH EFFECT - IMPACT CODE TO CHRONIC DISEASE FOR PAIN, THE PATIENT WAS NOT REVISED. DEVICES USED FOR THIS SURGERY WERE CONFIRMED AND UPDATED. D10. 0999305; 200-03-35 - ONE PEG PATELLA 35MM. 1123069; 234-03-03 - OPTETRAK ASY,PS CEMENTED FEMORAL, SZ 3. 1131262; 200-04-33 - CEMENTED FINNED TIB. TRA SZ 3F/3T. H6. INVESTIGATION-BASED ON REVIEW OF ALL AVAILABLE INFORMATION, THERE IS NO EVIDENCE TO SUGGEST THAT THE REPORTED EVENT IS RELATED TO ANY DESIGN ISSUES. THE CAUSE OF THE PATIENT'S PAIN CANNOT BE CONCLUSIVELY DETERMINED; HOWEVER, IT IS MOST LIKELY RELATED TO THE PATIENT¿S UNDERLYING CONDITION AS ASSOCIATED WITH THE INTERACTION BETWEEN THE IMPLANTED DEVICE AND THE PATIENT DUE TO PATIENT ILLNESS, UNIQUE ANATOMY, OR OTHER CONDITION THAT IMPACTS THE PERFORMANCE OF THE DEVICE. THE PATIENT HAS BILATERAL KNEE REPLACEMENTS. THESE DEVICES ARE USED FOR TREATMENT NOT DIAGNOSIS. H6 HEALTH EFFECT - IMPACT CODE THE PATIENT WAS NOT REVISED.

    Description of Event or Problem · 0

    IT WAS REPORTED VIA A LEGAL NOTIFICATION, THAT PATIENT, UNDERWENT INITIAL BILATERAL KNEE REPLACEMENT SURGERY ON (B)(6) 2008 AND WAS IMPLANTED WITH A OPTETRAK DEVICE. SPECIFICALLY, PLAINTIFF WAS IMPLANTED WITH A OPTETRAK POSTERIOR STABILIZED TIBIAL INSERT, ALONG WITH AN OPTETRAK STEM, OPTETRAK PATELLA, OPTETRAK SCREWS, A OPTETRAK TIBIAL TRAY, AND A OPTETRAK POSTERIOR STABILIZED FEMORAL COMPONENT. FOLLOWING THE SURGERY, PLAINTIFF BEGAN EXPERIENCING WORSENING SYMPTOMS, PAIN, INSTABILITY, EFFUSION, AND ANTALGIC GATE. PLAINTIFF HAS NOT YET UNDERGONE A REVISION SURGERY OF HER RIGHT KNEE AS OF TODAY. PLAINTIFF CONTINUES TO EXPERIENCE PAIN AND DISCOMFORT ON A DAILY BASIS IN BOTH OF HER KNEES WHICH LIMITS HER DAILY ACTIVITIES AND QUALITY OF LIFE. NO DEVICE RETURN ANTICIPATED DUE TO THIS BEING A LEGAL CASE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    335387 OPTETRAK SEE H10 JWH EXACTECH, INC. PS TIBIAL INSERTS SZ 3, 11MM UNK 10885862048318

    Patients

    Seq Age Sex Outcome Treatment
    1 68 YR Female Required Intervention SEE H10.